Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical symbols : JNJ save search
Incyte Breaks Mid-April M&A Lull With Escient Purchase
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | $26.15 1.28% 1.26% 12K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | $26.15 1.28% 1.26% 12K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
companies biopharma platform
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
reminyl pharma acquisition
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
sales revenue stelara
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
Avalo Snags Former Eli Lilly Asset and $185M in Major Pipeline Pivot
Published: 2024-03-29 (Crawled : 15:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
pipeline
Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton
Published: 2024-03-26 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
ponvory drug sclerosis pharmaceuticals
Novo, AbbVie, Lonza Boost Portfolios, Manufacturing as Part of 2024 M&A Upswing
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon
Published: 2024-03-18 (Crawled : 14:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
health
Biopharma Mergers and Acquisitions Continue to Trend Upward in 2024
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
acquisitions biopharma
Biden Turns Up Heat on Big Pharma’s Drug Prices in State of the Union Address
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
drug state
AstraZeneca Loses Court Challenge to Inflation Reduction Act
Published: 2024-03-01 (Crawled : 21:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
astrazeneca
FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia Hopeful
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.11%
H: 0.98%
C: -0.68%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -1.4%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
fda schizophrenia
FDA Decisions: Allecra Succeeds Where Competitors Failed; Another Humira Copycat
Published: 2024-02-27 (Crawled : 15:00) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: -10.69%
H: 0.0%
C: -4.98%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
fda humira
How Upcoming KRAS Inhibitors are Expected to Shape the Future Oncology Market Landscape?
Published: 2024-02-26 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
RVMD | $36.25 -0.49% -0.5% 1.4M
|
Health Technology
|
| O: 0.4%
H: 2.75%
C: 1.74%
IOVA M | $11.86 4.77% 4.55% 3.9M
|
Health Technology
|
| O: 0.19%
H: 9.37%
C: 5.06%
expected market
EU Panel Backs J&J, Legend’s Carvykti for Second-Line Multiple Myeloma
Published: 2024-02-26 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
carvykti
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.